Companies: 10,795·Total market cap: $144.5T
RegeneRx Biopharmaceuticals, Inc.

RegeneRx Biopharmaceuticals, Inc.

RGRXOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$898
P/E Ratio
52W High$0.163
52W Low$0.0002
Overview

RegeneRx Biopharmaceuticals, Inc. (RGRX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · RGRX · as of Apr 11, 2023

Latest filing snapshot

2
-1-33.33%vs prior year

RegeneRx Biopharmaceuticals, Inc. (RGRX) employee data is sourced from the annual SEC 10-K filing. As of 2022, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2022-12-31·Full-time · Global
Total Employees
2
Change (1Y)
-1
Growth % (1Y)
-33.33%
Revenue / Employee
$38.4K
Net Income / Employee
$-863.5K
Market Cap
$0M

RGRX Employee Count

1995 – 2022 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2023-04-112-1-33.33%
2022-03-303+0+0.00%
2021-03-023+0+0.00%
2020-03-203+0+0.00%
2019-03-293+0+0.00%
2018-03-293+0+0.00%
2017-03-293+0+0.00%
2016-04-113+1+50.00%
2015-03-312-3-60.00%
2014-04-045-1-16.67%

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
4Front Ventures Corp.
FFNTF
4Front Ventures Corp.
374
#2
Hemagen Diagnostics, Inc.
HMGN
Hemagen Diagnostics, Inc.
15
#3
ChitogenX Inc.
CHNXF
ChitogenX Inc.
5
#4
RegeneRx Biopharmaceuticals, Inc.
RGRX
RegeneRx Biopharmaceuticals, Inc.YOU
2
#5
Forza Innovations Inc.
FORZ
Forza Innovations Inc.
2
#6
Quantum Medical Transport, Inc.
DRWN
Quantum Medical Transport, Inc.
1
#7
BioSyntech, Inc.
BSYI
BioSyntech, Inc.
N/A
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · RGRX peer comparison

About RGRX employees

RGRX Employees · Headcount

RegeneRx Biopharmaceuticals, Inc. (RGRX) employee data is sourced from the annual SEC 10-K filing. As of 2022, RegeneRx Biopharmaceuticals, Inc. had 2 full-time employees globally. Full-time employees only. Global consolidated headcount.

RegeneRx Biopharmaceuticals, Inc. employs 2 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $38,381, reflecting the company's operational efficiency.

RegeneRx Biopharmaceuticals, Inc.'s workforce decreased by 1 (33.33%) in 2022 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

RegeneRx Biopharmaceuticals, Inc.'s revenue per employee of $38,381 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

RGRX Employees · 5 questions

As of the latest SEC 10-K filing (2022), RegeneRx Biopharmaceuticals, Inc. had 2 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

RegeneRx Biopharmaceuticals, Inc. employee counthow many employees does RegeneRx Biopharmaceuticals, Inc. haveRGRX total employees 2022

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2023-04-11